by University of Texas at El Paso Renato Aguilera, Ph.D., a professor of biological sciences at The University of Texas at El Paso, holds up a vial of pyronaridine, an anti-malarial drug that he recently patented for use in cancer treatments. As a longtime cancer researcher, Aguilera realized that the molecular structure of pyronaridine could be...
Tag: <span>Malaria drug</span>
Post
Malaria drug could combat chemotherapy-resistant head and neck cancers
UNIVERSITY OF PITTSBURGH IMAGE: UMAMAHESWAR DUVVURI, M.D., PH.D., HEAD AND NECK SURGEON AT UPMC HILLMAN CANCER CENTER AND PROFESSOR OF OTOLARYNGOLOGY IN PITT’S SCHOOL OF MEDICINE CREDIT: COURTESY OF UPMC PITTSBURGH, March 14, 2022 — A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in...